Literature DB >> 8099490

The epidemiology of HIV-1 infection of the lung in AIDS patients.

J R Clarke1, I K Taylor, J Fleming, A Nukuna, J D Williamson, D M Mitchell.   

Abstract

OBJECTIVE: To examine the relationship between HIV-1 infection of cells obtained by bronchoalveolar lavage (BAL) from the lung and the pathogenesis of AIDS.
DESIGN: Prospective study of 121 consecutive HIV-1-seropositive patients undergoing investigation for respiratory symptoms or abnormal chest radiograph.
METHODS: Polymerase chain reaction (PCR) for the detection of HIV-1-specific proviral DNA. Cocultivation of leukocytes obtained from BAL with donor cord blood leukocytes (CBL) to isolate HIV-1.
RESULTS: HIV-1 was detected by PCR in the lung cells of 78 out of 121 (65%) patients. It was detected in 55% of patients who had been seropositive for less than 1 year, but in over 80% of patients who had been seropositive for more than 3 years. HIV-1 was isolated from 61 out of 106 (58%) individuals. The ability to detect or isolate HIV-1 from the lung correlated directly to CD4 cell count in peripheral blood. HIV-1 was detected significantly more frequently in the BAL cells of smokers compared with non-smokers (P = 0.01).
CONCLUSIONS: HIV-1 was frequently detected and isolated from the lung of AIDS patients undergoing a respiratory episode. HIV-1 infection of the lung became more frequent with time from serodiagnosis. Patients who smoked were more likely to succumb to HIV-1 infiltration into the lung and HIV-1 infection of the lung was associated with progression to death.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8099490     DOI: 10.1097/00002030-199304000-00015

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  15 in total

Review 1.  The role of cytokines in the pathogenesis and treatment of HIV infection.

Authors:  Marta Catalfamo; Cecile Le Saout; H Clifford Lane
Journal:  Cytokine Growth Factor Rev       Date:  2012-06-26       Impact factor: 7.638

Review 2.  AIDS and the lung: update 1995. 4. Role of the human immunodeficiency virus within the lung.

Authors:  J R Clarke; D S Robinson; R J Coker; R F Miller; D M Mitchell
Journal:  Thorax       Date:  1995-05       Impact factor: 9.139

3.  Interactions between opportunistic micro-organisms and HIV in the lung.

Authors:  J R Clarke; D Israel-Biet
Journal:  Thorax       Date:  1996-09       Impact factor: 9.139

4.  BAL fluid analysis and HIV-1 infection.

Authors:  J R Clarke; J D Williamson; D M Mitchell
Journal:  Thorax       Date:  1995-06       Impact factor: 9.139

5.  HIV-1 proviral DNA copy number in peripheral blood leucocytes and bronchoalveolar lavage cells of AIDS patients.

Authors:  J R Clarke; A J Gates; R J Coker; J A Douglass; J D Williamson; D M Mitchell
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

6.  Does analysis of bronchoalveolar lavage fluid provide a tool to monitor disease progression or to predict survival in patients with HIV-1 infection?

Authors:  C Agostini; G Semenzato
Journal:  Thorax       Date:  1994-09       Impact factor: 9.139

7.  Patterns of chemokine receptor fusion cofactor utilization by human immunodeficiency virus type 1 variants from the lungs and blood.

Authors:  A Singh; G Besson; A Mobasher; R G Collman
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

8.  Relation of HIV-I in bronchoalveolar lavage cells to abnormalities of lung function and to the presence of Pneumocystis pneumonia in HIV-I seropositive patients.

Authors:  J R Clarke; I K Taylor; J Fleming; J D Williamson; D M Mitchell
Journal:  Thorax       Date:  1993-12       Impact factor: 9.139

Review 9.  Iron withholding: a defense against viral infections.

Authors:  E D Weinberg
Journal:  Biometals       Date:  1996-10       Impact factor: 2.949

10.  Longitudinal evaluation of prostaglandin E2 (PGE2) and periodontal status in HIV+ patients.

Authors:  Tamer Alpagot; John Remien; Mouchumi Bhattacharyya; Krystyna Konopka; William Lundergan; Nejat Duzguneş
Journal:  Arch Oral Biol       Date:  2007-06-27       Impact factor: 2.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.